Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

866 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Potential classification criteria for rheumatoid arthritis after two years: results from a French multicenter cohort.
Saraux A, Tobón GJ, Benhamou M, Devauchelle-Pensec V, Dougados M, Mariette X, Berenbaum F, Chiocchia G, Rat AC, Schaeverbeke T, Rincheval N, Meyer O, Fautrel B, Combe B. Saraux A, et al. Among authors: meyer o. Arthritis Care Res (Hoboken). 2013 Aug;65(8):1227-34. doi: 10.1002/acr.21982. Arthritis Care Res (Hoboken). 2013. PMID: 23401491 Free article.
Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort.
Baillet A, Gossec L, Paternotte S, Etcheto A, Combe B, Meyer O, Mariette X, Gottenberg JE, Dougados M. Baillet A, et al. Among authors: meyer o. Arthritis Care Res (Hoboken). 2015 Jul;67(7):905-12. doi: 10.1002/acr.22513. Arthritis Care Res (Hoboken). 2015. PMID: 25384758 Free article.
Choice of second-line disease-modifying antirheumatic drugs after failure of methotrexate therapy for rheumatoid arthritis: a decision tree for clinical practice based on rheumatologists' preferences.
Fautrel B, Guillemin F, Meyer O, de Bandt M, Berthelot JM, Flipo RM, Lioté F, Maillefert JF, Wendling D, Saraux A, Combe B, Le Loët X; Stratégies Thérapeutiques dans La Polyarthrite RhumatoIde Working Group; Club Rhumatismes et Inflammation; French Society of Rheumatology. Fautrel B, et al. Among authors: meyer o. Arthritis Rheum. 2009 Apr 15;61(4):425-34. doi: 10.1002/art.24588. Arthritis Rheum. 2009. PMID: 19333993 Free article.
Determining a low disease activity threshold for decision to maintain disease-modifying antirheumatic drug treatment unchanged in rheumatoid arthritis patients.
de Bandt M, Fautrel B, Maillefert JF, Berthelot JM, Combe B, Flipo RM, Lioté F, Meyer O, Saraux A, Wendling D, Le Loët X, Guillemin F; STPR group of the French Society of Rheumatology. de Bandt M, et al. Among authors: meyer o. Arthritis Res Ther. 2009;11(5):R157. doi: 10.1186/ar2836. Epub 2009 Oct 23. Arthritis Res Ther. 2009. PMID: 19849865 Free PMC article.
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
Combe B, Rincheval N, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loët X, Logeart I, Mariette X, Meyer O, Ravaud P, Saraux A, Schaeverbeke T, Sibilia J. Combe B, et al. Among authors: meyer o. J Rheumatol. 2013 Oct;40(10):1650-7. doi: 10.3899/jrheum.121515. Epub 2013 Aug 15. J Rheumatol. 2013. PMID: 23950185
Validation of FLARE-RA, a Self-Administered Tool to Detect Recent or Current Rheumatoid Arthritis Flare.
Fautrel B, Morel J, Berthelot JM, Constantin A, De Bandt M, Gaudin P, Maillefert JF, Meyer O, Pham T, Saraux A, Solau-Gervais E, Vittecoq O, Wendling D, Erpelding ML, Guillemin F; STPR Group of the French Society of Rheumatology. Fautrel B, et al. Among authors: meyer o. Arthritis Rheumatol. 2017 Feb;69(2):309-319. doi: 10.1002/art.39850. Arthritis Rheumatol. 2017. PMID: 27636400
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.
Soubrier M, Puéchal X, Sibilia J, Mariette X, Meyer O, Combe B, Flipo RM, Mulleman D, Berenbaum F, Zarnitsky C, Schaeverbeke T, Fardellone P, Dougados M. Soubrier M, et al. Among authors: meyer o. Rheumatology (Oxford). 2009 Nov;48(11):1429-34. doi: 10.1093/rheumatology/kep261. Epub 2009 Sep 9. Rheumatology (Oxford). 2009. PMID: 19741011 Clinical Trial.
866 results